Assertio Therapeutics is a drug manufacturers-specialty & generic business based in the US. Assertio Therapeutics stocks (ASRT.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.62 – a decrease of 2.31% over the previous week. Assertio Therapeutics employs 30 staff and has a trailing 12-month revenue of around $162.2 million.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $6.35 |
|---|---|
| 52-week range | $2.07 - $8.01 |
| 50-day moving average | $6.30 |
| 200-day moving average | $4.26 |
| Wall St. target price | $9.75 |
| PE ratio | 3.5876 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $1.77 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $6.35 from 2023-06-02
| 1 week (2023-05-26) | -2.31% |
|---|---|
| 1 month (2023-05-05) | 3.25% |
| 3 months (2023-03-03) | 2.25% |
| 6 months (2022-12-05) | 93.01% |
| 1 year (2022-06-03) | 99.06% |
|---|---|
| 2 years (2021-06-04) | 252.78% |
| 3 years (2020-06-05) | 537.93% |
| 5 years (2018-06-05) | 6.35 |
Valuing Assertio Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Assertio Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
| Revenue TTM | $162.2 million |
|---|---|
| Operating margin TTM | 35.37% |
| Gross profit TTM | $138.3 million |
| Return on assets TTM | 9.52% |
| Return on equity TTM | 53.56% |
| Profit margin | 59.86% |
| Book value | $4.50 |
| Market capitalisation | $353.5 million |
TTM: trailing 12 months
We're not expecting Assertio Therapeutics to pay a dividend over the next 12 months.
Assertio Therapeutics's shares were split on a 1:4 basis on 17 May 2021. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Assertio Therapeutics shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Assertio Therapeutics shares which in turn could have impacted Assertio Therapeutics's share price.
Over the last 12 months, Assertio Therapeutics's shares have ranged in value from as little as $2.07 up to $8.01. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Assertio Therapeutics's is 1.3962. This would suggest that Assertio Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Assertio Holdings, Inc. , a commercial pharmaceutical company, provides medicines in the areas of neurology, rheumatology, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; Zipsor, a NSAID for relief of mild to moderate pain in adults; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; and Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
